Kezar Life Sciences (KZR) Return on Assets (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Return on Assets for 5 consecutive years, with 0.63% as the latest value for Q4 2025.

  • For Q4 2025, Return on Assets fell 9.0% year-over-year to 0.63%; the TTM value through Dec 2025 reached 0.63%, down 9.0%, while the annual FY2025 figure was 0.49%, 4.0% down from the prior year.
  • Return on Assets hit 0.63% in Q4 2025 for Kezar Life Sciences, down from 0.59% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.21% in Q3 2022 and bottomed at 0.63% in Q4 2025.
  • Average Return on Assets over 5 years is 0.41%, with a median of 0.43% recorded in 2023.
  • Year-over-year, Return on Assets increased 9bps in 2022 and then decreased -23bps in 2024.
  • Kezar Life Sciences' Return on Assets stood at 0.31% in 2021, then rose by 28bps to 0.23% in 2022, then plummeted by -92bps to 0.43% in 2023, then dropped by -25bps to 0.54% in 2024, then fell by -17bps to 0.63% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.63%, 0.59%, and 0.6% for Q4 2025, Q3 2025, and Q2 2025 respectively.